Thai researchers assigned 121 patients undergoing heart bypass surgery to placebo or curcuminoids.
Turmeric’s anti-inflammatory potential may offer heart protection following a surgery called coronary artery bypass grafting (CABG), according to research published in The American Journal of Cardiology.
Previous research has found cardioprotective potential when humans or animals supplemented with curcuminoid, an active compound found in turmeric root and popularly marketed in dietary supplements.
CABG, also known as heart bypass surgery, is a method of treating coronary heart disease. The procedure is not without its own post-procedure risks, which include heart attack, stroke, and pain.
Thai researchers recruited 121 subjects scheduled to undergo CABG and assigned them to 4 g of curcuminoid (an active compounds in turmeric) or placebo daily. Supplementation began three days before surgery and continued until five days after surgery.
Subjects who supplemented with placebo experienced a 30% risk of heart attack after surgery, compared with a lesser 13% risk in the curcuminoid group. Other markers of pain and inflammation, including C-reactive protein and malondialdehyde, were improved with curcumin over placebo.
The researchers suspect that the antioxidant and anti-inflammatory effects of curcuminoids may have been responsible for heart-protective effects.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.